Ruane Cunniff Goldfarb, managers of the Sequoia Fund, recently released the transcript from its investor day. In it, they talk about many of their investments.
Their top ten holdings as of the end of the second quarter were: Berkshire Hathaway (BRK.A/B), TJX Companies (TJX), MasterCard (MA), Alphabet (GOOG/L), O'Reilly Auto (ORLY), Mohawk Industries (MHK), Fastenal (FAST), Rolls Royce (RR.L), Constellation Software (CSU.T), and Dentsply Sirona (XRAY).
They outline their thinking on Rolls Royce and also address the Valeant Pharmaceuticals (VRX) saga, which they no longer own.
Embedded below is the transcript of Ruane Cunniff's 2016 Investor Day:
You can download a .pdf copy here.
Tuesday, August 30, 2016
Ruane Cunniff (Sequoia Fund) Investor Day Transcript 2016: Rolls Royce, Valeant & More
Thursday, August 27, 2015
Sequoia Fund Investor Day Transcript 2015 (Ruane Cunniff & Goldfarb)
Ruane Cunniff & Goldfarb recently released their Sequoia Fund investor day transcript for 2015. While the event took place back in May, it's still interesting to get their insight on their investments given their long term focus.
Sequoia Fund's investment management team discussed their thesis and outlook on numerous portfolio companies, including Valeant, Google, Mohawk, Idexx, Fastenal, Rolls Royce, TJX, O'Reilly, and many more.
At the end of the second quarter, Sequoia Fund's top holdings were:
Valeant Pharmaceuticals (VRX): 28.7% of portfolio
Berkshire Hathaway (BRK.A/B): 10.6%
TJX Companies (TJX): 5%
O'Reilly Automotive (ORLY): 4.3%
Fastenal (FAST): 4.2%
MasterCard (MA): 3.2%
Precision Castparts (PCP): 2.7%
Mohawk Industries (MHK): 2.5%
Idexx Laboratories (IDXX): 2.3%
Google (GOOGL): 2%
This really is an interesting read in its entirety given their candidness about assessing their positions.
Embedded below is Sequoia Fund's investor day transcript for 2015:
You can download a .pdf copy here.
Monday, August 3, 2015
Third Point's Q2 Letter: Allergan, Suzuki Motor, Constellation Brands, Mohawk, Roper
Dan Loeb's hedge fund firm Third Point is out with its second quarter letter. The hedge fund has generated annualized returns of 20.5% over the last two decades.
Third Point's Q2 letter outlines their thesis on 5 stocks. Here's the brief summary with the full letter below.
Allergan (AGN): Formerly Actavis, this company recently sold its generics business for ~17x EBITDA and Third Point thinks the company is poised to grow as a pure-play pharma company. Branded assets + unlevered balance sheet + valuation below comparables = opportunity.
Suzuki Motor: This could be largely viewed as a play on India to capitalize on a growing middle class given the company's stake in Maruti as more people purchase cars. Overhang on shares due to litigation with Volkswagen.
Constellation Brands (STZ): The next three stocks Third Point has labeled as 'compounders,' or companies that have good management and generate a lot of cash flow that's then allocated wisely to drive returns. They see margin improvement and solid volume trends for this alcoholic beverage company and also think capital return to shareholders will ramp up further once capex comes down.
Mohawk (MHK): This global flooring company is at the beginning of a cyclical recovery and seeing margin improvement. They also see a lot of potential acquisition targets for the company.
Roper (ROP): This company has generated 18% annualized shareholder returns over the last 10 years. ROP runs a decentralized strategies and acquires a lot of companies. They like the company's organic revenue growth and think it'll see a 15% CAGR going forward.
Embedded below is Third Point's Q2 letter:
You can view additional portfolio activity from Third Point here.
Wednesday, January 7, 2015
Viking Global Reduces Illumina, Mohawk Industries Stakes
Andreas Halvorsen's hedge fund Viking Global has filed two separate 13G's with the SEC regarding some of their positions.
Reduces Illumina Stake
First, Viking has disclosed they now own 5.8% of Illumina (ILMN) with over 8.18 million shares. This is a decrease of 461,081 shares since the end of the third quarter. The filing was made due to portfolio activity on January 2nd.
Per Google Finance, Illumina is "a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies."
Cuts Mohawk Industries Position
Second, the hedge fund firm has revealed they own 5.5% of Mohawk Industries (MHK) with over 4 million shares. They've reduced their position by over 1.63 million shares since the end of the third quarter. The filing was required due to activity on January 2nd.
Per Google Finance, Mohawk Industries is "a flooring manufacturer. The Company's manufacturing and distribution processes provide carpet, rugs, ceramic tile, laminate, wood, stone and vinyl flooring. The Company's key brands include American Olean, Bigelow, Daltile, Durkan, Karastan, Kerama Marazzi, Lees, Marazzi, Mohawk, Pergo, Quick-Step and Unilin. The Company has three reporting segments: the Carpet segment, the Ceramic segment and the Laminate and Wood segment. The Carpet segment designs, manufactures, sources, distributes and markets its carpet and rug products. The Carpet segment also markets and distributes ceramic tile, laminate, hardwood, resilient floor covering, carpet pad and flooring accessories. The Ceramic segment designs, manufactures, sources, distributes and markets ceramic tile, porcelain tile and natural stone products. The Laminate and Wood segment designs, manufactures, sources, licenses, distributes and markets laminate and hardwood flooring."
We've also highlighted some other recent portfolio activity from Viking Global here.
Monday, March 18, 2013
Ruane Cunniff Goldfarb: Sequoia Fund Annual Letter 2012
Catching up on a few more notable 2012 annual letters, we turn next to the Sequoia Fund run by Ruane Cunniff & Goldfarb. An investment of $10,000 at inception in 1970 has grown to over $2.89 million as of the end of 2012. They returned 15.68% in 2012.
Key Takeaways
- They currently don't see many compelling investment opportunities. Began 2012 with 21% cash position, ended the year with 16%
- "In the fourth quarter of 2012, we were modest net sellers of equities for the first time since 2008, in response to specific situations at several of our portfolio holdings." They exited Target (TGT) and Becton Dickinson (BDX).
- "Valuations for stocks are heavily influenced by interest rates, and particularly by the risk-free rate of return on 10-year and 30-year United States Treasury bonds. Relative to the current return on Treasury Bonds, stocks continue to be quite attractive.However, the current risk-free rate of return is not a product of market forces. Rather, it is an instrument of Federal Reserve policy."
Top Holdings At 2012 Year-End
1. Valeant Pharmaceuticals (VRX): 11.6% of assets
2. Berkshire Hathaway (BRK.A): 10.9%
3. TJX (TJX): 7.5%
4. Fastenal (FAST): 5.6%
5. Mohawk Industries (MHK): 4.0%
6. Idexx Laboratories (IDXX): 3.2%
7. Advance Auto Parts (AAP): 3.1%
8. Precision Castparts (PCP): 3.1%
9. Rolls-Royce (LON:RR): 3.0%
Embedded below is Ruane Cunniff's annual letter from the Sequoia Fund where they go into detail about some of their positions and overall market views:
For more on this fund, late last year we posted up why Ruane Cunniff likes Valeant Pharmaceuticals.
Tuesday, September 20, 2011
Mark Massey's Hedge Fund AltaRock on Domino's, Mohawk Industries, & Carter's
Today we present an update from Mark Massey's hedge fund AltaRock. Since his inception as portfolio manager, Massey has seen a compound annual growth rate of 11.9%. And through the end of July, AltaRock was up 17.6% net for the year. While that obviously doesn't include the August volatility, it's certainly impressive.
Last year we posted up AltaRock's investing principles and received a ton of positive reader feedback about the piece. Since their letter was theoretical and practical in nature, the one question readers kept asking was: what are they invested in and why? Clearly everyone wanted to see these principles in practice.
Well today we're happy to share AltaRock's mid-year 2011 letter which walks you through their rationale with very in-depth write-ups on the following new additions to their portfolio: Domino's Pizza (DPZ), Mohawk Industries (MHK), and Carter's (CRI).
Massey writes that, "we invest with the mindset of a long-term business owner, and we seek superior businesses with durable competitive advantages."
Embedded below is the update (email readers please click this link to come read it: AltaRock's 2011 letter):
Be sure to also check out AltaRock's investing principles as it truly is an excellent piece.